Norma Drimmer and Sruel Prajs are visionary philanthropists whose dedication to advancing science, education, and medical innovation has left a lasting mark on Tel Aviv University. Guided by a deep belief in the power of research to improve lives, they have championed initiatives that support scientific excellence and create opportunities for future generations of researchers and clinicians.

 

Their transformative generosity led to the establishment of the Prajs-Drimmer Institute for the Development of Anti-Degenerative Drugs, a pioneering center dedicated to advancing research on neurodegenerative diseases and accelerating the translation of scientific discoveries into potential therapies. By bringing together experts from medicine, life sciences, engineering, and neuroscience, the Institute promotes interdisciplinary collaboration and innovative approaches to some of the most pressing challenges in human health.

 

Through their vision and commitment, the Prajs and Drimmer families have helped strengthen Tel Aviv University's position as a global center of biomedical innovation. Their legacy continues to inspire groundbreaking research, support emerging scientific talent, and contribute to a future in which new discoveries can improve the lives of patients around the world.